This trial represents a single institution phase I/II pilot study with the primary objective of establishing the safety and feasibility of generating and infus…

AML, ChildhoodAmlAcute Myeloid Leukemia, Pediatric+1 more

~Estimated

~$10 – $6,250

Washington University School of MedicineNCT06158828

Phase 1

CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies

The study participant has one of the following blood cancers: acute myelogenous leukemia (AML)/myelodysplastic syndrome (MDS), acute lymphoblastic leukemia (B-…

Hematologic MalignancyALL, ChildhoodAML, Childhood+2 more

~Estimated

~$10 – $6,250

St. Jude Children's Research HospitalNCT06326463